Home Cart Sign in  
Chemical Structure| 225791-13-9 Chemical Structure| 225791-13-9
Chemical Structure| 225791-13-9

(1S,2R)-2-Aminocyclopentanol HCl

CAS No.: 225791-13-9

4.5 *For Research Use Only !

Cat. No.: A222393 Purity: 95%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇî¶ÊÊ Inquiry Inquiry
1g łÍò¶ÊÊ Inquiry Inquiry
5g łÇî§¶ÊÊ Inquiry Inquiry
10g ł§Ëî¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇî¶ÊÊ

  • 1g

    łÍò¶ÊÊ

  • 5g

    łÇî§¶ÊÊ

  • 10g

    ł§Ëî¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 225791-13-9 ]

CAS No. :225791-13-9
Formula : C5H12ClNO
M.W : 137.61
SMILES Code : O[C@@H]1[C@H](N)CCC1.[H]Cl
MDL No. :MFCD08704797
InChI Key :ZFSXKSSWYSZPGQ-JBUOLDKXSA-N
Pubchem ID :17039404

Safety of [ 225791-13-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Computational Chemistry of [ 225791-13-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 34.87
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

46.25 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.38
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.66
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.21
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.14
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.28

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.93
Solubility 16.1 mg/ml ; 0.117 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.92
Solubility 16.7 mg/ml ; 0.121 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.2
Solubility 220.0 mg/ml ; 1.6 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.87 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.79

Application In Synthesis of [ 225791-13-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 225791-13-9 ]

[ 225791-13-9 ] Synthesis Path-Downstream   1~18

  • 1
  • (S,R)-4,5,6,6a-tetrahydro-2-methyl-3aH-cyclopentoxazole hydrochloride [ No CAS ]
  • [ 225791-13-9 ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; In methanol; ethanol; C. Preparation of cis-2-aminocyclopentanol hydrochloride The 60.36 g of crude intermediate from Example 2B above were stirred with 566 ml of 10% hydrochloric acid solution at reflux for one hour. After cooling, the mixture was filtered and the filtrate was concentrated in vacuo. To the residue were added 200 ml of methanol and the mixture again concentrated in vacuo. Fifty milliliters of ethanol were added and the solution was placed in the refrigerator. The resulting precipitate was collected by filtration, washed with cold ethanol, and recrystallized from ethyl acetate/methanol to provide 20.18 g of the desired title intermediate, m.p. 182-184 C.
  • 2
  • [ 1345818-00-9 ]
  • [ 225791-13-9 ]
  • [ 1345818-04-3 ]
YieldReaction ConditionsOperation in experiment
60.3% With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 100℃; for 3h; A mixture of N-cyclopropyl-2-(2,5-dichloropyrimidin-4-yl)-l-(ethoxymethyl)-lH- indole-4-carboxamide (10 g, 25 mmol), (15',2i?)-2-aminocyclopentanol hydrochloride (4.1 g, 30 mmol) and DIPEA (5 mL, 30 mmol) in DMSO (70 mL) is stirred at 100 C for 3 h, then poured into water and extracted with EA. The combined extracts are washed with aqueous saturated sodium chloride, dried over Na2S04 and concentrated in vacuo. The residue is purified by chromatography on silica gel to give 2-{5-chloro-2-[(li?,25)-2- hydroxycyclopentylamino] pyrimidin-4-yl} -N-cyclopropyl- 1 -(ethoxymethyl)- lH-indole- 4-carboxamide (7 g, 60.3 %). MS (m/z): 470 (35C1) and 472 (37C1) (M+H)+ The above product (7 g, 14.9 mmol) is stirred with hydrogen chloride (6 M in methanol, 210 mL, 1.26 mol) at 45 C for 12 h. The precipitate is collected by filtration, washed with methanol and dried in vacuo to give the title compound (4.7 g, 70 %). MS (m z): 412 (35C1) and 414 (37C1) (M+H)+.
  • 3
  • [ 1572515-74-2 ]
  • [ 225791-13-9 ]
  • [ 1572511-91-1 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In dichloromethane; for 0.5h; General procedure: Procedure S2: A tube was charged with 3-[(4-fluoro-3-methyl-phenyl)carbamoyl]- benzenesulfonyl chloride (250 mg, 0.76 mmol) and an amine (1.1 eq) and CH2C12 (5 mL) was added. The solution was stirred, DIPEA (329 mu, 1.9 mmol, 2.5 eq) was added and the mixture was further stirred for 30 minutes. Then, HC1 (1M aq / 5 mL) was added and the mixture was stirred for 5 minutes more. Compound 172 Synthesis following procedure S2 with cis-(15',2i?)-2-aminocyclopentanol hydrochloride as amine. The formed precipitate was collected on a glassfilter and rinsed with CH2CI2 (2 x 5 mL). The precipitate was further purified using silica gel column chromatography (gradient elution: EtO Ac-heptane 0: 100 to 100:0). Drying in vacuo at 55C resulted in compound 172 as a bright white powder. Method G; Rt: 1.65 min. m/z: 392.9 (M+H)+ Exact mass: 392.1. DSC (From 30 to 300 C at 10C/min): 145 C.
  • 4
  • [ 1414772-61-4 ]
  • [ 225791-13-9 ]
  • [ 1610454-07-3 ]
YieldReaction ConditionsOperation in experiment
11% With sodium hydrogencarbonate; In butan-1-ol; at 150℃; for 72h; 150 mg (0.56 mmol) 3-(1-benzofur-2-yl)-6-chloroimidazo[1,2-b]pyridazine, 183.7 mg (1.34 mmol) <strong>[225791-13-9](1S,2R)-2-aminocyclopentanol hydrochloride</strong> (1:1) and 186.9 mg (2.23 mmol) sodium hydrogencarbonate in 5.0 mL butan-1-ol were stirred 72 h at 150C. The solvent was removed. The residue was purified by HPLC to yield 20 mg (11%). LC-MS (Method 2): Rt = 1.01 min; MS (ESIpos) m/z = 335 [M+H]+. 1H-NMR (300 MHz ,DMSO-d6), delta [ppm]= 1.54-2.12 (6H), 3.96-4.08 (1H), 4.29-4.36 (1H), 4.70-4.76 (1H), 6.90-6.97 (1H), 6.99-7.05 (1H), 7.20-7.32 (2H), 7.47-7.51 (1H), 7.56-7.61 (1H), 7.64-7.70 (1H), 7.74-7.80 (1H), 7.87-7.91 (1H)
  • 5
  • 6-(4-chlorophenyl)-2-(3-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid [ No CAS ]
  • [ 225791-13-9 ]
  • 6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-[(1R,2S)-2-hydroxycyclopentyl]-3-oxo-2,3-dihydropyridazine-4-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
34 mg With dmap; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 3h; A solution of 75 mg intermediate 17, 59.9 mg (1 S,2R)-2-amino-cyclopentanol hydrochloride (1 :1 ), 165.5 mg HATU, 0.1 1 mL ethyldiisopropylamine and 1 .3 mg 4-dimethylaminopyridine in 2 mL of DMF was stirred at room temperature for 3 hours. Then the reaction mixture was filtered and subjected to RP-HPLC (Instrument: Labomatic HD-3000 HPLC gradient pump, Labomatic Labocol Vario-2000 fraction collector; column: Chromatorex C-18 125 mm x 30 mm, eluent A: 0.1 % formic acid in water, eluent B: acetonitril; gradient: A 60% / B 40%? A 20% / B 80%; flow: 150 mL/min; UV-detection: 254 nm) to yield 34 mg 6-(4-chlorophenyl)-2-(3- fluorophenyl)-N-[(1 R,2S)-2-hydroxycyclopentyl]-3-oxo-2,3-dihydropyridazine-4-carboxamide. 1H NMR (400 MHz, DMSO-d6) delta ppm = 1 .45 - 1.66 (m, 3 H), 1 .66 - 1 .90 (m, 2 H), 1 .92 - 2.03 (m, 1 H), 3.97 - 4.1 1 (m, 2 H), 5.03 (d, 1 H), 7.35 - 7.41 (m, 1 H), 7.51 - 7.68 (m, 5 H), 7.97 - 8.03 (m, 2 H), 8.66 (s, 1 H), 9.67 - 9.74 (m, 1 H).
  • 6
  • 2-(3-fluorophenyl)-6-(4-methoxyphenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid [ No CAS ]
  • [ 225791-13-9 ]
  • 2-(3-fluorophenyl)-N-[(1R,2S)-2-hydroxycyclopentyl]-6-(4-methoxyphenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
36 mg With dmap; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 14h; A solution of 83 mg intermediate 2-(3-fluorophenyl)-6-(4-methoxyphenyl)-3-oxo-2,3- dihydropyridazine-4-carboxylic acid, 37 mg (1 S,2R)-2-aminocyclopentanol hydrochloride, 167 mg HATU, 0.12 mL ethyldiisopropylamine and 1 .3 mg 4-dimethylaminopyridine in 1 .6 mL of DMF was stirred at room temperature for 14 hours. Then the reaction mixture was filtered and subjected to RP-HPLC (Instrument: Waters Autopurificationsystem; column: Waters XBrigde C18 5mu 100x30mm; eluent A: water + 0.2 Vol-% aqueous ammonia (32%), eluent B: methanol; gradient: 0.00-0.50 min 32% B (25->70mL/min), 0.51-5.50 min 67-87% B (70mL/min), DAD scan: 210-400 nm) to yield 36 mg 2-(3-fluorophenyl)-N-(3-hydroxybutan-2-yl)-6-(4- methoxyphenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide. 1H NMR (400 MHz, DMSO-d6) delta ppm = 1 .45 - 1.68 (m, 3 H), 1 .70 - 1 .89 (m, 2 H), 1 .89 - 2.06 (m, 1 H), 3.82 (s, 3 H), 3.96 - 4.12 (m, 2 H), 5.02 (d, 1 H), 7.00 - 7.15 (m, 2 H), 7.29 - 7.45 (m, 1 H), 7.51 - 7.57 (m, 1 H), 7.57 - 7.69 (m, 2 H), 7.86 - 7.94 (m, 2 H), 8.62 (s, 1 H), 9.74 (d, 1 H).
  • 7
  • [ 32315-10-9 ]
  • [ 225791-13-9 ]
  • [ 135969-62-9 ]
YieldReaction ConditionsOperation in experiment
260 mg A mixture of <strong>[225791-13-9](1S,2R)-2-aminocyclopentanol hydrochloride</strong> (compound 27a, 500 mg, 3.63 mmol) and potassium hydroxide (1.83 g, 32.7 mmol) in water (25 mL) was stirred at 0 oC for 2 hours, then THF (50 mL) and triphosgene (2.16 g, 7.27 mmol) was added slowly, the reaction mixture was stirred at 0 oC for 2 hours. The reaction mixture was poured into 20 mL H2O and extracted with EtOAc twice (50 mL). The combined organic layer was washed with sat. aqueous sloution of NaHCO3 (50 mL) and brine (50 mL), dried over Na2SO4 and concentrated in vacuo. The residue was washed with n-heptane to give compound 27b (260 mg) as a white solid. LCMS (M+H+): 128.1.
  • 8
  • 6-(4-chlorophenyl)-3-oxo-2-(pyridin-3-yl)-2,3-dihydropyridazine-4-carboxylic acid [ No CAS ]
  • [ 225791-13-9 ]
  • 6-(4-chlorophenyl)-N-[(1R,2S)-2-hydroxycyclopentyl]-3-oxo-2-(pyridin-3-yl)-2,3-dihydropyridazine-4-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
35 mg With dmap; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20℃; for 1.5h; A solution of 75 mg intermediate 6-(4-chlorophenyl)-3-oxo-2-(pyridin-3-yl)-2,3-dihydropyridazine-4-carboxylic acid, 63 mg (1 S,2R)-2-aminocyclopentanol hydrochloride (1:1),174 mg HATU, 0.16 mL ethyldiisopropylamine and 1 mg 4-dimethylaminopyridine in 2 mL ofDMF was stirred at room temperature for 90 mm. Then the reaction mixture was filtered andsubjected to RP-HPLC (instrument: Labomatic HD-3000 HPLC gradient pump, LabomaticLabocol Vario-2000 fraction collector; column: Chromatorex C-18 125 mm x 30 mm, eluent A:0.lvol% formic acid in water, eluent B: acetonitrile; gradient: A 70% I B 30% - A 30% I B70%; flow: 150 mLlmin; UV-detection: 254 nm) to yield 35 mg 6-(4-chlorophenyl)-N-[(1 R,2S)-2-hydroxycyclopentyl]-3-oxo-2-(pyridin-3-yl)-2,3-d ihyd ropyridazine-4-carboxamide.1H NMR (400 MHz, DMSO-d6) 6 [ppm] = 1.46 - 1.64 (m, 3 H), 1.70 - 1.88 (m, 2 H), 1.92 - 2.03(m, 1 H), 3.99 -4.12 (m, 2 H), 5.04 (d, 1 H), 7.56 - 7.61 (m, 2 H), 7.61 - 7.66 (m, 1 H), 7.97 -8.03 (m, 2 H), 8.16 (ddd, 1 H), 8.66 - 8.70 (m, 2 H), 8.91 (d, 1 H), 9.67 (d, 1 H).
  • 9
  • 3-oxo-2-(pyridin-3-yl)-6-[4-(trifluoromethyl)phenyl]-2,3-dihydropyridazine-4-carboxylic acid [ No CAS ]
  • [ 225791-13-9 ]
  • N-[(1R,2S)-2-hydroxycyclopentyl]-3-oxo-2-(pyridin-3-yl)-6-[4-(trifluoromethyl)phenyl]-2,3-dihydropyridazine-4-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
59% With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; 3-Oxo-2-(pyridin-3-yl)-6-[4-(trifluoromethyl )phenyl]-2 ,3-di hydropyridazi ne-4-carboxylic acid (50 mg, 0.138 mmol) was dissolved in anhydrous DMF (1.05 mL). (1S,2R)-2-Aminocyclopentanolhydrochloride (1:1) (38 mg, 0.28 mmol), N-ethyl-N-isopropylpropan-2-amine (157 pL, 0.90 mmol), and propane phosphonic acid anhydride (T3P, 122 pL, 50% in DMF, 208 pmol) were successively added. It was stirred for 2 h at rt. The reaction mixture was diluted with methanol and concentrated under vacuum. The residue was purified by RP-HPLC (column: X-Bridge 018 5pm 1 OOx3Omm, mobile phase: (water + 0.2 vol% aqueous ammonia (32%)) acetonitrile,gradient) to afford 36.5 mg (59%) of the title compound.1H-NMR (400MHz, DMSO-d6): 6 [ppm] = 1.46 - 1.65 (m, 3H), 1.70- 1.88 (m, 2H), 1.92-2.04(m, 1H), 3.99 -4.12 (m, 2H), 5.05 (d, 1H), 7.64 (ddd, 1H), 7.89 (d, 2H), 8.18 (ddd, 1H), 8.21 (d,2H), 8.70 (dd, 1H), 8.75 (s, 1H), 8.92 (d, 1H), 9.66 (d, 1H).= -2.1 (c = 1.00, methanol).
  • 10
  • C15H19F2NO4 [ No CAS ]
  • [ 225791-13-9 ]
  • tert-butyl [(2S)-2-[2,4-difluoro-6-([(1R,2S)-2-hydroxycyclopentyl]amino}methyl)phenoxy]propyl]carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
42% A solution of ( 1.V,2/?)-2-aminocyclopentanol HC1 salt (104 mg, 0.76 (0491) pmol) and A-3-2 (200 mg, 634 pmol) in dry MeOH (3.17 mL) was heated to 65 C for 1 hour. The reaction was cooled to room temperature and NaBFL (72 mg, 1.9 mmol) was added. The mixture was stirred for 2 hours then quenched with water (5 mL) and stirred for 5 min. The mixture was extracted with DCM (3 x 15 mL), dried with Na2S04 and concentrated under reduced pressure. Flash chromatography (ISCO system, silica (12 g), 0-20% methanol in dichloromethane) provided A-3 (108 mg, 270 pmol, 42% yield).
  • 11
  • [ 123-11-5 ]
  • [ 225791-13-9 ]
  • C13H19NO2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
84.98% ( 1 R, 25)-2-aminocyclopentanol, HC1 (3.6 g, 26.16 mmol) was dissolved in anhydrous MeOH (96.89 mL) and treated with strongly basic ion exchange resin (Amberlite IRN-78). 4-methoxybenzaldehyde (3.56 g, 26.16 mmol) was added and the solution was stirred and heated to 65 C for 3 hr. The mixture was cooled to room temperature and NaBH4 (989.68 mg, 26.16 mmol) was added. The reaction was stirred for 30 minutes, then quenched with water (50 mL) and stirred for another 30 minutes. MeOH was removed under reduced pressure and the aqueous phase was extracted with DCM (3 x 50mL). The organic phase was combined and dried over Na2S04. The crude was purified by flash chromatography (ISCO system, 80g, 0-10% MeOH/DCM) to give C-5-1 (4.92 g, 22.23 mmol, 84.98% yield)
  • 12
  • ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate [ No CAS ]
  • [ 225791-13-9 ]
  • C14H17FN4O3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
97% With N-ethyl-N,N-diisopropylamine; In ethanol; at 80℃; for 1h; To a solution of C-l-5 (1.74 g, 7.1 mmol) and the HC1 salt of (lS,2^)-2- aminocyclopentanol (1.08 g, 7.8 mmol) in EtOH (14 mL) was added DIEA (4.6 g, 6.2 mL 35.6 mmol). The mixture was heated to 80 C for 1 hour. The reaction cooled and concentrated under reduced pressure. Flash chromatography (ISCO system, silica (40 g), 20-80% ethyl acetate in hexane) provided C-l-6 (2.13 g, 97% yield) as a white solid.
  • 13
  • C15H20FNO4 [ No CAS ]
  • [ 225791-13-9 ]
  • tert-butyl [(2S)-2-[4-fluoro-2-([(1R,2S)-2-hydroxycyclopentyl]amino}methyl)phenoxy]propyl]carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
64.9% A solution of ( 1.V , 2 /? ) - 2 - a m i n o c y c 1 o pe n t a n o 1 HC1 salt (69 mg, 504 pmol), Hunig?s Base (196 mg, 0.26 mL, 1.5 mmol) and A-1-4 (150.00 mg, 504 pmol) in dry MeOH (2.50 mL) was heated to 65 C for 1 hr. The reaction was cooled to room temperature and NaBFL (38 mg, 1.0 mmol) was added. The mixture was stirred for 2 hr then quenched with water (3 mL) and stirred for 5 min. The mixture was extracted with DCM (3 x 5 mL), dried with Na2S04 and concentrated under reduced pressure. Flash chromatography (ISCO system, silica (12 g), 25-50% ethyl acetate in hexane) provided A-l (125.3 mg, 327 pmol, 64.9% yield).
  • 14
  • [ 24424-99-5 ]
  • [ 225791-13-9 ]
  • [ 913631-66-0 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In dichloromethane; at 16℃; for 12h; To a solution of (1S, 2R)-2-aminocyclopentanol, hydrochloride (2 g, 14.53 mmol, 1 eq) in DCM (20 mL) was added TEA (4.41 g, 43.60 mmol, 6.07 mL, 3 eq) and Boc2O (3.17 g, 14.53 mmol, 3.34 mL, 1 eq). The mixture was stirred at l6C for 12 h. It was concentrated under reduced pressure to remove DCM. The residue was diluted with water 50 mL, adjusted pH to 7 by added HC1 (1 M), and then extracted with EtOAc (30 mLx3). The combined organic layers were washed with brine (50 mL), dried over Na2S04, filtered and concentrated under reduced pressure to afford the title compound (2.5 g, crude) as a colorless oil whcih was used directly into the next step without purification.
  • 15
  • 2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-2-phenylpropanoic acid [ No CAS ]
  • [ 225791-13-9 ]
  • 2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-N-((1R,2S)-2-hydroxycyclopentyl)-2-phenylpropanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
65% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; A mixture of 2- (5-amino-2- (furan-2-yl) -7H-pyrazolo [4, 3-e] [1, 2, 4] triazolo [1, 5-c] pyrimidin-7-yl) -2-phenylpropanoic acid (38.9 mg, 0.1 mmol) , (1S, 2R) -2-aminocyclopentan-1-ol hydrochloride (13.7 mg, 0.1 mmol) , HATU (45 mg, 0.12 mmol) and DIPEA (25.8 mg, 0.2 mmol) in DMF (3 mL) was stirred overnight. The reaction mixture was poured into H 2O (10 mL) and extracted with EtOAc (10 mL x 3) . The combined organic layers were washed with brine, dried over Na 2SO 4, concentrated and purified by prep -TLC (EtOAc) to give the target compound (31 mg, 65%) . 1H NMR (400 MHz, DMSO-d6) delta 8.28 -8.25 (m, 1H) , 7.98 (s, 2H) , 7.96 (s, 1H) , 7.38 -7.22 (m, 4H) , 7.19 -7.07 (m, 2H) , 6.95 -6.81 (m, 1H) , 6.79 -6.70 (m, 1H) , 4.66 -4.56 (m, 1H) , 4.00 -3.79 (m, 2H) , 2.34 (d, J = 10.4 Hz, 3H) , 1.89 (m, 1H) , 1.78 -1.54 (m, 3H) , 1.31 -1.21 (m, 2H) ppm. MS: M/e 473 (M+1) +.
  • 16
  • (S)-2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-2-phenylpropanoic acid [ No CAS ]
  • [ 225791-13-9 ]
  • (S)-2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-N-((1R,2S)-2-hydroxycyclopentyl)-2-phenylpropanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
52.4% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; A mixture of (S) -2- (5-amino-2- (furan-2-yl) -7H-pyrazolo [4, 3-e] [1, 2, 4] triazolo [1, 5-c] pyrimidin-7-yl) -2-phenylpropanoic acid (100 mg, 0.26 mmol) , (1S, 2R) -2-aminocyclopentan-1-ol hydrochloride (35.3 mg, 0.26 mmol) , HATU (120 mg, 0.31 mmol) and DIPEA (67 mg, 0.52 mmol) in DMF (4 mL) was stirred overnight. The reaction mixture was poured into H 2O (10 mL) and extracted with EtOAc (10 mL x 3) . The combined organic layers were washed with brine, dried over Na 2SO 4, concentrated and purified by prep -TLC (EtOAc) to give the target compound (53 mg, 52.4%) . 1H NMR (400 MHz, DMSO-d6) delta 8.28 -8.25 (m, 1H) , 7.98 (s, 2H) , 7.96 (s, 1H) , 7.38 -7.22 (m, 4H) , 7.19 -7.07 (m, 2H) , 6.95 -6.81 (m, 1H) , 6.79 -6.70 (m, 1H) , 4.66 -4.56 (m, 1H) , 4.00 -3.79 (m, 2H) , 2.34 (d, J = 10.4 Hz, 3H) , 1.89 (m, 1H) , 1.78 -1.54 (m, 3H) , 1.31 -1.21 (m, 2H) ppm. MS: M/e 473 (M+1) +.
  • 17
  • (R)-2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-2-phenylpropanoic acid [ No CAS ]
  • [ 225791-13-9 ]
  • (R)-2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-N-((1R,2S)-2-hydroxycyclopentyl)-2-phenylpropanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
52.4% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; A mixture of (R) -2- (5-amino-2- (furan-2-yl) -7H-pyrazolo [4, 3-e] [1, 2, 4] triazolo [1, 5-c] pyrimidin-7-yl) -2-phenylpropanoic acid (100 mg, 0.26 mmol) , (1S, 2R) -2-aminocyclopentan-1-ol hydrochloride (35.3 mg, 0.26 mmol) , HATU (120 mg, 0.31 mmol) and DIPEA (67 mg, 0.52 mmol) in DMF (4 mL) was stirred overnight. The reaction mixture was poured into H 2O (10 mL) and extracted with EtOAc (10 mL x 3) . The combined organic layers were washed with brine, dried over Na 2SO 4, concentrated and purified by prep-TLC (EtOAc) to give the target compound (50 mg, 52.4%) . 1H NMR (400 MHz, DMSO-d6) delta 8.28 -8.25 (m, 1H) , 7.98 (s, 2H) , 7.96 (s, 1H) , 7.38 -7.22 (m, 4H) , 7.19 -7.07 (m, 2H) , 6.95 -6.81 (m, 1H) , 6.79 -6.70 (m, 1H) , 4.66 -4.56 (m, 1H) , 4.00 -3.79 (m, 2H) , 2.34 (d, J = 10.4 Hz, 3H) , 1.89 (m, 1H) , 1.78 -1.54 (m, 3H) , 1.31 -1.21 (m, 2H) ppm. MS: M/e 473 (M+1) +.
  • 18
  • 5-((2-(6-(3'-(5-formyl-6-methoxypyridin-2-yl)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)-2-methoxypyridin-3-yl)-4,5-dihydro-1H-imidazol-1-yl)methyl)nicotinonitrile [ No CAS ]
  • [ 225791-13-9 ]
  • [ 76-05-1 ]
  • 5-((2-(6-(3'-(5-((((1R,2S)-2-hydroxycyclopentyl)amino)methyl)-6-methoxypyridin-2-yl)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)-2-methoxypyridin-3-yl)-4,5-dihydro-1H-imidazol-1-yl)methyl)nicotinonitrile bis(trifluoroacetate) [ No CAS ]
YieldReaction ConditionsOperation in experiment
Crude 5 -((2-(6-(3? -(5 -formyl-6-methoxypyridin-2-yl)-2,2? -dimethyl- [ 1 , G -biphenyl] -3 -yl)-2- methoxypyridin-3-yl)-4,5-dihydro-lH-imidazol-l-yl)methyl)nicotinonitrile (18 mg, 0.025 mmol), diisopropylethylamine (13 mg, 0.1 mmol), and (lS,2R)-2-aminocyclopentan-l-ol hydrochloride (18 mg, 0.13 mmol) was suspended in dichloromethane. The resulting mixture was stirred at room temperature for 0.5 h before NaBH(OAc)3 (44 mg, 0.2 mmol) was added. The reaction was stirred for 4 h and quenched with TFA, water and DMF. After stirring for 15 min, the reaction was concentrated and purified by preparative HPFC to provide the title compound as the bis-TFA salt. ' H NMR (400 MHz, Methanol-iA) d 8.91 (d, J= 1.9 Hz, 1H), 8.76 (d, J= 2.2 Hz, 1H), 8.22 (t, J= 2.1 Hz, 1H), 8.08 (d, J= 7.7 Hz, 1H), 7.86 (d, J= 7.5 Hz, 1H), 7.48 (dd, .7= 7.7, 1.4 Hz, 1H), 7.45 - 7.31 (m, 4H), 7.26 (dd, .7= 7.6, 1.5 Hz, 1H), 7.23 - 7.15 (m, 2H), 4.76 (s, 2H), 4.38 (td, J= 4.6, 2.2 Hz, 1H), 4.28 (q, J= 13.3 Hz, 2H), 4.18 - 4.08 (m, 4H), 4.05 (s, 3H), 3.98 (s, 3H), 3.54 - 3.43 (m, 1H), 2.20 - 2.06 (m, 7H), 2.06 - 1.58 (m, 5H). ES/MS (m/z, M+H+): 694.71.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 225791-13-9 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 68327-11-7

A187080 [68327-11-7]

(1R,2R)-2-aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 68327-04-8

A212536 [68327-04-8]

(1S,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 31775-67-4

A346501 [31775-67-4]

trans-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 137254-03-6

A219695 [137254-03-6]

(1R,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 59260-76-3

A403690 [59260-76-3]

trans-2-Aminocyclopentanol

Similarity: 0.96

Alcohols

Chemical Structure| 68327-11-7

A187080 [68327-11-7]

(1R,2R)-2-aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 68327-04-8

A212536 [68327-04-8]

(1S,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 31775-67-4

A346501 [31775-67-4]

trans-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 137254-03-6

A219695 [137254-03-6]

(1R,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 59260-76-3

A403690 [59260-76-3]

trans-2-Aminocyclopentanol

Similarity: 0.96

Amines

Chemical Structure| 68327-11-7

A187080 [68327-11-7]

(1R,2R)-2-aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 68327-04-8

A212536 [68327-04-8]

(1S,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 31775-67-4

A346501 [31775-67-4]

trans-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 137254-03-6

A219695 [137254-03-6]

(1R,2S)-2-Aminocyclopentanol hydrochloride

Similarity: 1.00

Chemical Structure| 59260-76-3

A403690 [59260-76-3]

trans-2-Aminocyclopentanol

Similarity: 0.96